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SUMMARY
Over a 13 year period, 544 chemical lumbar sympathetic blocks with phenol
in 489 patients were performed by the author with the aid of X-ray image
intensification. There was objective and subjective improvement in the signs
and symptoms of limb ischaemia in 72%, judged by relief of rest pain,
improvement in skin blood flow or healing of ischaemic ulcers. Of patients
treated in the years 1990-1993, 44% had suffered either death or major
amputation within two years of their treatment. Three serious and probably
avoidable complications are described.
INTRODUCTION
Perhaps no procedure has generated more controversy in the treatment of
peripheral vascular disease than lumbar sympathectomy. Surgical section of
the lumbarsympathetic chain was first performed in 1923 to alleviate muscular
rigidity associated with spastic paralysis in warwounded. The obvious effecton
the lower limb vasculature was immediately apparent, and the following year
an operation was carried out in the Mayo clinic for Raynaud's phenomenon. At
about the same time chemical lumbar sympathectomy was being carried out
in Vienna and the vascular aspect of this work was soon evident. Reid and
colleagues in 1970 reported the long term follow-up results of a large series of
cases with ischaemic rest pain treated with phenol sympathetic block.'
In the normal subject a complete sympathetic blockade leads to visibly dilated
veins or increased blood flow, seen clinically in reduced capillary refilling time.
Vasoconstrictor reflexes such as the cold or "ice" response are abolished. The
blood flow increase is largely restricted to the skin, with an increase in skin
temperature and feeling of warmth in the extremity. Skin capillary oxygen
tension and venous oxygen tension are increased. Muscle blood flow is usually
unaffected so that intermittent claudication may not be helped. It is not always
possible to predict the effect of sympathetic blockade in a patient with a
diseased vascular system as a "steal" phenomenon may occur although this is
rare. The main indication for sympathetic blockade is rest pain and ischaemic
cutaneous ulcers in a limb not amenable to direct arterial reconstruction.
Associated coronary artery disease, pulmonary disease and other physical
conditions in the aged make some patients poor candidates for surgery. The
mechanism whereby the sympathetic nervous system is involved in peripheral
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pain has not been fully elucidated. The cutaneous pain threshold via a negative
feedback loop is influenced by sympathetic efferents, and some afferent
pathwaysinvolvedinischaemicpainarebelievedtopassthroughthesympathetic
nervous system.
This paper presents a review of 544 neurolytic lumbar sympathetic blocks
performed for peripheral vascular disease in the 13 year period ending
December 1993. All the procedures were carried out by the author using
radiological control.
METHODS
The technique used is a modification ofthe classical method.2 The patient lies
in the lateral position with the side to be treated uppermost, on an X-ray
translucent operating table, and is lightly sedated with intravenous ketamine
20-50 mg and Diazemuls 5-10 mg. Adequate monitoring is provided by pulse
oximetry. A skin wheal is raised with local anaesthetic about 10 cm lateral to
the midline ofthe back at the level of L3 vertebra. A 22 gauge 150 mm needle
is directed to strike the body of L3 and then manipulated to slide offthe antero-
lateral surface ofthe vertebral body so that the tip lies near the anterior surface
ofthe vertebrae. A second needle is directed cephalad to lie in a similar position
in relation to L2. Correct position of the needles is confirmed using a C-arm
image intensifier and careful aspiration performed to ensure that the needle tip
is not in a blood vessel. A small volume of 10% phenol in Conray - 420 contrast
medium is injected. IfX-ray confirms that the solution is spreading correctly in
a thin linear fashion that conforms to the anterior edge of the vertebrae, a
maximum of 2 ml of the phenol in contrast medium is injected through each
needle. A thermal print-out hard copy confirming correct spread of contrast is
obtained, and 1-2 ml air injected through each needle to clear the neurolytic
agent before withdrawal. Patients remain in the lateral position for 20-30
minutes to limit spread of solution laterally towards the genito-femoral nerve
or posteriorly towards the somatic nerves. Patients were interviewed within 24
hours and a clinical assessment made of the success of the procedure. No
special testswereperformed. Results werearbitrarily gradedasgood, improved
or unchanged depending on the adequacy of relief of rest pain and the clinical
appearance of increased skin blood flow and warmth in the foot.
RESULTS
Five hundred andforty-four blocks wereperformed on489 patients; 55 patients
had bilateral blocks, on separate occasions The male tofemale ratiowas I/1.05
and the average age 72 years (range 14-95). Twenty-eight patients were less
than 50 years-of-age and five ofthese were females having bilateral treatments
for severe vasospastic disease (Raynaud's phenomenon or chilblains). All
patients were referred for treatment by one offour vascular surgeons. Patients
were interviewed 24 hours after the block had been performed and a clinical
evaluation made. Where the foot was obviously warmer, with hyperaemia and
complete reliefofrest pain, the block was graded as good (40%). Many ofthese
patients spontaneously volunteered that they had had the first good nights
sleep for weeks. Patients who had objective or subjective evidence of lesser
degrees of warming ofthe foot or incomplete relief of rest pain were graded as
improved (32%). Thus a favourable response was obtained in 72% of all
patients. No detectable change was seen in the remaining 28% and they were
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graded as unchanged or poor. Thirty-seven patients were diabetic and a
favourable response to the block was obtained in 54%.
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Fig. 1 Proportion of the subgroup of 148 patients remaining alive (upper line, 20% died),
remaining amputation free (middle line, 24% had above or below knee amputation) or suffering
neither death or amputation (lower line). Four patients who died within 6 months of amputation
are not included in the deaths.
In an effort to establish the long-term fate ofthese patients, a chart review was
undertaken of the 148 patients treated during the period January 1990 to
December 1993. The mean follow-up period was 8 months (range 3 days -42
months). Twenty patients could not betraced. Thirty patients (20%) are known
to have died within two years of their treatment and an additional 34 (24%)
suffered a major (above or below knee) amputation. Thus 44%ofthis subgroup
of patients suffered a major complication (death or amputation) within two
years (Figure 1). Four had died within six months of amputation and these
deaths are not included in Figure 1. Six patients became bilateral amputees.
Fifty-two (35%) of this subgroup had good long-term improvement in the
condition ofthe treated limb with healing of ischaemic ulcers and relief of rest
pain. In five there was return of peripheral pulses which had been absent and
in one only the claudication distance improved. Twelve of these 148 patients
© The Ulster Medical Society, 1994.
139The Ulster Medical Journal
were diabetic, ofwhom two were dead within a year and five had undergone a
below-knee amputation within six months giving an unfavourable outcome in
58%. Three of the diabetic patients had satisfactory circulation in the treated
limb at one year.
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Fig. 2 The response to sympathetic block was graded as good (27), improved (52) or poor (49).
Solid bars represent deaths, hatched bars amputations, stippled bars survival with satisfactory
circulation, plain bars survival withcontinuing circulatory problems; allexpressed as a percentage
for each group.
Grading the success of the block as good, improved or poor according to the
clinical evaluation was somewhat arbitrary, and Figure 2 is designed tojustify
this classification. The figure shows that in the good responders, deaths and
amputations were less likely, and the chance of survival with satisfactory
circulation in the treated limb high (62%). In the poor responders, death or
amputation occurred in 68%. Those patients graded as improved occupied an
intermediate position. The incidence of minor amputations (toes) without loss
of the limb was 12%
Complications
Minor complications were more commonly observed in the earlier treatments.
In the first 200 patients, nine minor adverse effects were seen, and these
included hypotension (2), convulsions (3) or severe nausea and vomiting (2).
Larger doses of phenol were used in these patients, and the unwanted effects
were presumably caused either by accidental intravascular injection or by the
systemic toxic effects of phenol.
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Genito-femoral nerve irritation
Genito-femoral nerve neuritis or neuralgia is said to occur in 5-7% of patients
following chemical sympathectomy and is conventionally regarded as being
due to the neurolytic solution spreading to involve the genito-femoral nerve as
it lies on the anterior surface of the psoas muscle where it may be close to the
sympathetic chain. A similar complication can occur after surgical
sympathectomy, and the numbness, burning and hyperasthesia in the groin
may last for several weeks. There is a well recognised anatomical anomaly
where the genito-femoral nerve is fused with the sympathetic trunk for part of
its course, so some of these complications may be unavoidable.
Case I A 25-year-old female suffering from severe chilblains had a successful
neurolytic block performed. She developed a severe andapparently permanent
genito-femoral nerve lesion. Ten years later the area of hypersensitivity and
tenderness is still present although less acute. Permanentgenito-femoral nerve
irritation has not previously been described after chemical sympathectomy.
Psoas haematoma
Case 2 A 60-year-old male diabetic patient who had had a recent myocardial
infarct had an apparently technically satisfactory block performed. It was not
obvious in the medical notes that he was being treated with warfarin. He
subsequently complained of severe back and leg pain and a CT scan showed
a large haematoma in the psoas muscle. He suffered a fatal cardiac arrest five
days later.
Spinal paralysis
Case 3 A 76-year-old male diabetic patient developed a complete flaccid
paralysis belowthe waist 12 hours after a phenol sympathetic block. There had
been technical problems in getting a satisfactory spread of solution at the L3
level and it was suspected that a small amount of phenol solution was injected
intra arterially. He died suddenly four months later, without any sign of
neurological recovery. Autopsy revealed a recent occlusive thrombus in a
severely diseased coronary artery system, infarction ofthe lower lumbar spinal
cord, and a patent anterior spinal artery. It was suspected, but not confirmed,
thatthis individual was one ofthe few (1.4%) in whom the great radicular artery
of Adamkiewicz is supplied from the lumbar artery at the L3 level, and that
injection of phenol into or near this dominant artery caused a direct toxic or
ischaemic effect on the lower spinal cord.
DISCUSSION
Many studies have indicated that patients with rest pain, ulceration or limited
gangrene are likely to derive benefit from lumbar sympathectomy. Chemical
sympathectomy is a simple procedure to perform and in our hands the success
rate compares favourably with that claimed using computed tomography
control (72% versus 76%).4 It can be repeated if necessary although this only
occurred onceinthisseries. Wehavenotfoundspecial investigationsparticularly
helpful although younger patients would usually have a local anaesthetic block
performed with bupivacaine (Marcain) so that the effect of a permanent block
can be assessed. Because the numberofpatientswith vasculardisease is large,
complicated and time consuming physiological studies are notalwaysfeasible.
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It has generally been accepted thatthe ankle-brachial systolic pressure ratio or
index measured with a Doppler probe is important; if less than 0.35 the
response to sympathectomy is likely to be poor although rest pain may be
relieved. A recent study suggests that orthostatic responses to changes in limb
position as measured by a duplex ultrasound flowmeter may be used to predict
the clinical outcome to sympathectomy.5
In a recent reviewCotton andCrossconcludedthatsympathectomywas a good
procedure inend-stage diseasewhen nootheroptionwasopen;6therewas little
to support the addition of sympathectomy to a synchronous vascular
reconstruction as a way of improving graft patency; sympathectomy probably
does not postpone amputation or influence the level at which this will be
required. In general, the most beneficial effect of sympathectomy was relief of
restpain, with a somewhatlessereffectofimproved healingofulcers. Increased
walking tolerance was of benefit in a small group of patients with intermittent
claudication. Occasional dramatic deterioration has been described but is
sufficiently rare not to prevent sympathectomy from being widely used in the
treatment of ischaemic pain. Their general conclusion was that the use of
chemical sympathectomy inthecontrolofischaemic restpainandpregangrene
inthe lower limb is atleast as effective as open operation andthe high morbidity
and mortality of the latter is considerably reduced.6
The use of sympathectomy in diabetic patients has been questioned by some
workers. Although diabetic ischaemic disease increased the risk of failure of
sympathectomy, 54% of diabetics in the present series responded favourably
initially and in those patients who were followed upfor a longer period, 25% had
a good long term result. Our numbers are small but a 58% incidence of major
complication (death or amputation) within a year as against 44% for the group
as a whole would suggest that diabetics do less well, although some worthwhile
results can be obtained. Two recent publications take the view that diabetic
status has no prognostic value, and should be ignored.7'8 Ofequal concern are
the increasing numbersofrenaltransplant andchronicdialysis patientswho are
being referred with critical ischaemia.
I feel thatchemical lumbarsympathectomy is useful inthetreatmentofpatients
with severe lower limb ischaemia manifest as rest pain, ulceration or toe
gangrene, where arterial reconstruction is not feasible for technical or medical
reasons. It is of doubtful value in patients with massive tissue necrosis, deep
infection or forefoot gangrene, and the inability to salvage an effective walking
surface ofthefootwill ensurethatthe procedure is notsuccessful. Itcan be done
as a day procedure, although our preference would be that the patient stays in
hospital the night following the block. The very serious complications seen in
three patients could probably have been avoided. In many patients critical limb
ischaemia is an end-stage phenomenon, and almost 50% will suffer major
amputation or death within two years. Some patients are unable or unwilling to
stop smoking, and progression of their disease is inevitable.
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